Investments
1Portfolio Exits
1DekaTeam-BioTech Investments
1 Investments
DekaTeam-BioTech has made 1 investments. Their latest investment was in La Jolla Pharmaceutical Company as part of their Unattributed VC - IV on January 1, 2002.
DekaTeam-BioTech Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
1/18/2002 | Unattributed VC - IV | La Jolla Pharmaceutical Company | $51.59M | Yes | Alfred I. duPont Testamentary Trust, AWM Investment Company, Bain Capital Public Equity, Deerfield Management, Deka Investment, East Bay Municipal Utility District, EGS Healthcare Capital Partners, ING, J.P. Morgan Chase & Co., Memorial Hospital Of South Bend, Nemours Foundation, RS Investments, Safeco, SF Capital Group, UBS, Undisclosed Investors, Utah Retirement Systems, and Zeke |
Date | 1/18/2002 |
|---|---|
Round | Unattributed VC - IV |
Company | La Jolla Pharmaceutical Company |
Amount | $51.59M |
New? | Yes |
Co-Investors | Alfred I. duPont Testamentary Trust, AWM Investment Company, Bain Capital Public Equity, Deerfield Management, Deka Investment, East Bay Municipal Utility District, EGS Healthcare Capital Partners, ING, J.P. Morgan Chase & Co., Memorial Hospital Of South Bend, Nemours Foundation, RS Investments, Safeco, SF Capital Group, UBS, Undisclosed Investors, Utah Retirement Systems, and Zeke |
Sources |
DekaTeam-BioTech Portfolio Exits
1 Portfolio Exit
DekaTeam-BioTech has 1 portfolio exit. Their latest portfolio exit was La Jolla Pharmaceutical Company on February 06, 2006.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
2/6/2006 | IPO |
Date | 2/6/2006 |
|---|---|
Exit | IPO |
Companies | |
Valuation | |
Acquirer | |
Sources |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.